ArticleFrontiers in immunology2026

Avidity-optimized TCR-T cells target KRAS neoantigens for potent cancer clearance and tumor microenvironment remodeling.

Zhaoduan Liang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.